- Home
- INKT vs FLUX Comparison
INKT vs FLUX Comparison
Compare INKT & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | FLUX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 14.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | INKT | FLUX |
|---|---|---|
| Price | $10.95 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 8.4K | ★ 103.9K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,317,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 126.25 |
| 52 Week Low | $8.48 | $0.47 |
| 52 Week High | $18.17 | $7.55 |
Technical Indicators
Market Signals| Indicator | INKT | FLUX |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 33.50 |
| Support Level | $10.72 | $0.47 |
| Resistance Level | $12.61 | $1.18 |
| Average True Range (ATR) | 0.46 | 0.06 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 38.92 | 25.43 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.